Crystalvue Medical Co Ltd

Crystalvue Medical Co Ltd

TTPEX:6527
71.50
TWD
-0.50
(-0.69%)
5.96EPS
12.39P/E
1.90BMarket Cap
Mar 24Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
18.63
18.07
20.74
24.11
21.95
27.08
29.47
19.88
28.8
31.76
32.9
34.3
37.45
35.29
Basic EPS, GAAP
1.55
1.91
2.28
2.21
1.49
3.12
4.06
2.23
3.08
4.59
4.13
5.02
5.8
6.05
Free Cash Flow per Basic Share
0.2
2.52
-0.05
2.56
1.89
3.36
4.08
-0.79
-11.52
1.71
5.81
0.83
-1.82
-0.08
Dividend per Share
- -
- -
0.33
1.14
0.95
0.96
1.62
2.44
1.33
1.85
2.27
2.07
2.25
- -
Book Value per Share
12.97
14.84
17.13
18.19
18.73
20.57
27.52
26.94
28.69
31.23
33.92
37.21
40.58
42.26
Tangible Book Value per Share
12.76
14.79
17.07
18.15
18.7
20.54
27.48
24.17
28.65
31.16
33.73
37.05
40.48
42.22
Basic Weighted Avg Shares
22
22
22
22
22
22
22
25
25
25
25
25
25
25
Sales/Revenue/Turnover
404
398
465
542
494
606
661
504
722
795
824
868
949
895
Operating Margin (%)
8.09
9.78
12.04
10.48
7.49
12.73
17.25
11.43
12.26
15.69
14.28
16.71
19.07
20.21
Depreciation Expense
12
11
8
10
10
12
20
25
41
26
29
29
18
13
Net Income, GAAP
34
42
51
50
34
70
91
57
77
115
103
127
147
153
Effective Tax Rate (%)
17.36
22.21
19.01
19.78
9.23
13.02
18.49
10.08
29.25
19.24
13.65
20.22
17.89
19.1
Profit Margin (%)
8.33
10.56
11.01
9.15
6.8
11.53
13.78
11.23
10.7
14.46
12.55
14.65
15.49
17.15
Working Capital
267
314
357
378
386
415
657
550
330
400
495
467
380
359
LT Debt
- -
- -
- -
- -
- -
- -
44
38
31
25
19
12
5
90
Total Equity
292
334
385
409
421
462
702
675
719
776
857
939
1,028
1,071
Return on Invested Capital (%)
9.97
9.69
12.61
11.48
8.09
15.2
15.33
7.05
8.49
12.89
12.03
12.41
14.47
- -
Return on Capital (%)
12.43
13.45
14.24
12.49
8.09
15.83
15.22
7.87
10.58
14.82
12.33
13.88
14.76
- -
Return on Common Equity (%)
12.43
13.45
14.24
12.49
8.09
15.83
15.66
8.23
11.08
15.39
12.67
14.16
14.94
- -

Capital Structure

TWD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
7
7
7
LT Borrowings
- -
30
90
LT Finance Leases
3
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
25
25
25
Market Capitalization
1,792
1,853
1,901

Working Capital

TWD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
597
591
578
Cash, Cash Equivalents & STI
110
84
104
Accounts Receivable, Net
150
158
141
Inventories
323
335
306
Total Current Liabilities
341
292
220
Payables & Accruals
- -
- -
- -
ST Debt
7
7
7
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.09%
8.79%
9.59%
Free Cash Flow
-477.18%
212.75%
-319.18%
Net Income, GAAP
17.89%
22.76%
15.59%
Sales/Revenue/Turnover
8.74%
14.31%
9.33%
Total Cash Common Dividend
- -
3.26%
9.03%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
200
211
233
224
868
2025
224
256
- -
267
949
2026
188
218
221
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.24
1.28
1.33
1.18
5.02
2025
1.46
1.49
- -
1.49
5.8
2026
1.33
1.67
1.56
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2.07
2025
- -
- -
- -
- -
2.25
2026
- -
- -
- -
- -
- -

Company Description

CEO
Wei Wang
Full Time Employees
109
Sector
Health technology
Industry
Medical specialties
Address
No.116, Zhongshan Road Taoyuan TPE Taiwan 330
IPO Date
Apr 29, 2015
Business
Crystalvue Medical Corporation develops, produces, and distributes sophisticated ophthalmic diagnostic instruments across the globe. Established in 2009, the company specializes in a range of devices including advanced retinal cameras, optical coherence tomography (OCT) systems, tonometers, and automated lens edgers and tracers. Crystalvue also provides services for original design and equipment manufacturing, along with supplying endoscopic medical instruments. Their operations are headquartered in Taoyuan City, Taiwan, serving a worldwide clientele.